Hao L - Search Results

1

Tumor penetrating nanomedicine targeting both an oncomiR and an oncogene in pancreatic cancer.

Gilles ME, Hao L, Brown K, Lim J, Bhatia SN, Slack FJ. Gilles ME, et al. Among authors: hao l. Oncotarget. 2019 Sep 3;10(51):5349-5358. doi: 10.18632/oncotarget.27160. eCollection 2019 Sep 3. Oncotarget. 2019. PMID: 31523393 Free PMC article.

2

Personalized RNA Medicine for Pancreatic Cancer.

Gilles ME, Hao L, Huang L, Rupaimoole R, Lopez-Casas PP, Pulver E, Jeong JC, Muthuswamy SK, Hidalgo M, Bhatia SN, Slack FJ. Gilles ME, et al. Among authors: hao l. Clin Cancer Res. 2018 Apr 1;24(7):1734-1747. doi: 10.1158/1078-0432.CCR-17-2733. Epub 2018 Jan 12. Clin Cancer Res. 2018. PMID: 29330203

3

iRGD-guided Tumor-penetrating Nanocomplexes for Therapeutic siRNA Delivery to Pancreatic Cancer.

Lo JH, Hao L, Muzumdar MD, Raghavan S, Kwon EJ, Pulver EM, Hsu F, Aguirre AJ, Wolpin BM, Fuchs CS, Hahn WC, Jacks T, Bhatia SN. Lo JH, et al. Among authors: hao l. Mol Cancer Ther. 2018 Nov;17(11):2377-2388. doi: 10.1158/1535-7163.MCT-17-1090. Epub 2018 Aug 10. Mol Cancer Ther. 2018. PMID: 30097486 Free PMC article.

4

Acidification of Tumor at Stromal Boundaries Drives Transcriptome Alterations Associated with Aggressive Phenotypes.

Rohani N, Hao L, Alexis MS, Joughin BA, Krismer K, Moufarrej MN, Soltis AR, Lauffenburger DA, Yaffe MB, Burge CB, Bhatia SN, Gertler FB. Rohani N, et al. Among authors: hao l. Cancer Res. 2019 Apr 15;79(8):1952-1966. doi: 10.1158/0008-5472.CAN-18-1604. Epub 2019 Feb 12. Cancer Res. 2019. PMID: 30755444 Free PMC article.

5

Theranostic Layer-by-Layer Nanoparticles for Simultaneous Tumor Detection and Gene Silencing.

Boehnke N, Correa S, Hao L, Wang W, Straehla JP, Bhatia SN, Hammond PT. Boehnke N, et al. Among authors: hao l. Angew Chem Int Ed Engl. 2020 Feb 10;59(7):2776-2783. doi: 10.1002/anie.201911762. Epub 2020 Jan 7. Angew Chem Int Ed Engl. 2020. PMID: 31747099 Free PMC article.

6

Cancer Cell-Derived Matrisome Proteins Promote Metastasis in Pancreatic Ductal Adenocarcinoma.

Tian C, Öhlund D, Rickelt S, Lidström T, Huang Y, Hao L, Zhao RT, Franklin O, Bhatia SN, Tuveson DA, Hynes RO. Tian C, et al. Among authors: hao l. Cancer Res. 2020 Apr 1;80(7):1461-1474. doi: 10.1158/0008-5472.CAN-19-2578. Epub 2020 Feb 6. Cancer Res. 2020. PMID: 32029550 Free PMC article.

7

Microenvironment-triggered multimodal precision diagnostics.

Hao L, Rohani N, Zhao RT, Pulver EM, Mak H, Kelada OJ, Ko H, Fleming HE, Gertler FB, Bhatia SN. Hao L, et al. Nat Mater. 2021 Oct;20(10):1440-1448. doi: 10.1038/s41563-021-01042-y. Epub 2021 Jul 15. Nat Mater. 2021. PMID: 34267368

8

CRISPR-Cas-amplified urinary biomarkers for multiplexed and portable cancer diagnostics.

Hao L, Zhao RT, Welch NL, Tan EKW, Zhong Q, Harzallah NS, Ngambenjawong C, Ko H, Fleming HE, Sabeti PC, Bhatia SN. Hao L, et al. Nat Nanotechnol. 2023 Jul;18(7):798-807. doi: 10.1038/s41565-023-01372-9. Epub 2023 Apr 24. Nat Nanotechnol. 2023. PMID: 37095220 Free PMC article.

9

CRISPR-Cas-mediated Multianalyte Synthetic Urine Biomarker Test for Portable Diagnostics.

Van Heest AE, Deng F, Zhao RT, Harzallah NS, Fleming HE, Bhatia SN, Hao L. Van Heest AE, et al. Among authors: hao l. J Vis Exp. 2023 Dec 8;(202):10.3791/66189. doi: 10.3791/66189. J Vis Exp. 2023. PMID: 38145378 Free PMC article.

10

Inhalable point-of-care urinary diagnostic platform.

Zhong Q, Tan EKW, Martin-Alonso C, Parisi T, Hao L, Kirkpatrick JD, Fadel T, Fleming HE, Jacks T, Bhatia SN. Zhong Q, et al. Among authors: hao l. Sci Adv. 2024 Jan 5;10(1):eadj9591. doi: 10.1126/sciadv.adj9591. Epub 2024 Jan 5. Sci Adv. 2024. PMID: 38181080 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

4,282 results

Search Page

Filters